Instrumentation Laboratory Acquires CA Casyso

Instrumentation Laboratory (IL) (Bedford, MA, USA), which manufactures instruments and reagents for the global hemostasis market, has acquired CA Casyso AG (Basel, Switzerland) and its Tem subsidiaries (Tem), a provider of in vitro diagnostic (IVD) testing for patient blood management (PBM).

CA Casyso AG is the parent company of Tem Innovations, Tem International and Tem Systems, while IL is a part of the Werfen family of companies. Tem manufactures Rotem whole blood analyzers, which detect coagulopathies in hospital trauma and surgical patients with clinically significant bleeding to allow treatment with targeted therapy, thereby minimizing or preventing massive bleeding and hemorrhagic shock. The acquisition of CA Casyso AG and Tem will allow IL to complement and expand their leadership in hemostasis and critical care IVD through the product line in viscoelastic testing.

"A passion for innovation, leading systems and extensive knowledge in PBM, make Tem a perfect complement to our focus, commitment, and leadership in Hemostasis and Critical Care IVD," said Ramon Benet, CEO at IL. "IL and our global Werfen organizations are ideally positioned to maximize the potential of the ROTEM product line, which intersects our existing business and presents synergies in our core competencies and customer call points. Most importantly, ROTEM systems share the same ultimate benefit of all our products -- to help customers reduce overall hospital costs, while improving patient care."

Related Links:
Instrumentation Laboratory